Journal article icon

Journal article

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Sub department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Sub department:
Clinical Neurosciences
Role:
Author
Expand authors...
Publisher:
Elsevier BV Publisher's website
Journal:
Lancet Journal website
Volume:
395
Issue:
10234
Pages:
1407-1409
Publication date:
2020-04-09
Acceptance date:
2020-04-07
DOI:
EISSN:
1474-547X
ISSN:
0140-6736
Pmid:
32278362
Language:
English
Keywords:
Pubs id:
1101000
Local pid:
pubs:1101000
Deposit date:
2020-06-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP